Facial Rejuvenation Using Botulinum Toxin A: Review and Updates

Facial Plastic Surgery

Volumn 20, Issue 1, 2004, Pages 11-19

  Vartanian, A John ^b   Dayan, Steven H ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b Lasky Clinic   (United States)

Author keywords

Botox; Botox cosmetic; Botulinum toxin A; Facial rejuvenation

Indexed keywords

BOTULINUM TOXIN A; ELA MAX; EMLA;

ALLERGIC REACTION; ANESTHESIA; BLEPHAROSPASM; CONVALESCENCE; DRUG EFFECT; DRUG FORMULATION; DRUG MECHANISM; DRUG SAFETY; DYSPHONIA; DYSTONIA; EDEMA; ELECTROMYOGRAPHY; FACE SURGERY; FACIAL REJUVENATION; FLU LIKE SYNDROME; FOOD AND DRUG ADMINISTRATION; FUNCTIONAL ANATOMY; HEADACHE; HEMATOMA; HEMIFACIAL SPASM; HUMAN; INFORMED CONSENT; PATIENT SELECTION; REJUVENATION; REVIEW; RISK BENEFIT ANALYSIS; STRABISMUS; SURGICAL TECHNIQUE; TREATMENT INDICATION; WRINKLE;

BOTULINUM TOXIN TYPE A; FACE; HUMANS; NEUROMUSCULAR AGENTS; RHYTIDOPLASTY; SAFETY; SKIN AGING;

EID: 1842507406     PISSN: 07366825     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-822954     Document Type: Review

References (28)

1. Lowe NJ. Botulinum toxin type A for facial rejuvenation. United States and United Kingdom perspectives. Dermatol Surg 1998;24(11):1216-1218
2. Blitzer A, Binder WJ, Boyd JB, Carruthers A. Management of Facial Lines and Wrinkles. Philadelphia, PA: Lippincott Williams & Wilkins; 2000
3. Product Information Package Insert (71390US12J). Irvine, CA: Allergan, Inc.; 2002
4. Aoki RK. Immunologic and other properties of therapeutic botulinum toxin serotypes. In: Brin MF, Hallett M, Jankovic J, eds. Scientific and Therapeutic Aspects of Botulinum Toxin. Philadelphia, PA: Lippincott Williams & Wilkins; 2002
5. Singh BR. Molecular basis of the unique endopeptidase activity of botulinum neurotoxin. In: Brin MF, Hallett M, Jankovic J, eds. Scientific and Therapeutic Aspects of Botulinum Toxin. Philadelphia, PA: Lippincott Williams & Wilkins; 2002
6. Montecucco C, Schiavo G. Tetanus and botulinum neurotoxins: a new group of zinc proteases. Trends Biochem Sci 1993;18:324-327
7. de Paiva A, Meunier FA, Molgo J, et al. Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals. Proc Natl Acad Sci USA 1999;96(6):3200-3205
8. Ansved T, Odergren T, Borg K. Muscle fiber atrophy in leg muscles after bolutinum toxin type A for treatment of cervical dystonia. Neurology 1997;48:1440-1442
9. Hatheway CG. Immunology of Botulinum Toxin. New York: Marcel-Dekker; 1993
10. Carruthers JA, Kiene K, Carruthers JDA. Botulinum toxin use in clinical dermatology. J Am Acad Dermatol 1996;34:788-797
11. Matarasso SL. Complications of botulinum A exotoxin for hyperfunctional lines. Dermatol Surg 1998;24(11):1249-1254
12. Blitzer A, Binder WJ, Aviv JE. Current practices in the use of botulinum toxin A in the management of facial lines and wrinkles. Facial Plast Surg Clin North Am 2001;9(3):395-404
13. Lange DJ, Rubin M, Greene PE, et al. Distant effects of locally injected botulinum toxin: a double-blind study of single fiber EMG changes. Muscle Nerve 1991;14:672-675
14. Goschel H, et al. Botulinum toxin therapy, neutralizing and non-neutralizing antibodies. Exp Neurol 1997;147:96
15. Dressler D, Munchau A, Bhatia KP, Quinn NP, Bigalke H. Antibody induced botulinum toxin therapy failure. Eur Neurol 2002;47:118-121
16. Matarasso A, Deva AK. American Society of Plastic Surgeons DATA Committee. Botulinum toxin. Plast Reconstr Surg 2002;109(3):1191-1197
17. Scott AB. Clostridial toxins as therapeutic agents. In: Simpson L, ed. Botulinum Neurotoxin and Tetanus Toxin. New York: Academic Press; 1999:399-406
18. Jankovic N, Brin MF. Therapeutic uses of botulinum toxin. N Engl J Med 1991;324(17):1186-1193
19. Klein AW. Dilution and storage of botulinum toxin. Dermatol Surg 1998;24(11):1179-1180
20. Frankel AS, Kamer FM. Chemical browlift. Arch Otolaryngol Head Neck Surg 1998;124(3):321-323
21. Huilgol SC, Carruthers A, Carruthers JD. Raising eyebrows with botulinum toxin. Dermatol Surg 1999;25:373-375
22. Carucci JA, Zweibel SM. Botulin A exotoxin for rejuvenation of the upper third of the face. Facial Plast Surg 2001;17(1):11-19
23. Edelstein C, Shorr N, Jacobs J, Balch K, Goldberg R. Oculoplastic experience with the cosmetic use of botulinum A exotoxin. Dermatol Surg 1998;24:1208-1212
24. Manaloto RM, Alster TS. Periorbital rejuvenation: a review of dermatologic treatments. Dermatol Surg 1999;25(1):1-9
25. Guerrissi J, Sarkissian P. Local injection into mimetic muscles of botulinum toxin A for the treatment of facial lines. Ann Plast Surg 1997;39(5):447-453
26. Larrabee WF Jr, Makielski KH. Surgical Anatomy of the Face. New York: Raven Press; 1993
27. Brandt FS, Belhnan B. Cosmetic use of botulinum A exotoxin for the aging neck. Dematol Surg 1998;24:1232-1234
28. Carruthers JDA, Carruthers JA. Combining botulinum toxin injection and laser resurfacing for facial rhytids. In: Coleman W, Lawrence N, eds. Skin Resurfacing. Baltimore, MD: Williams &Wilkins; 1998:238-243